Bohai Pharmaceuticals Group, Inc. - FORM 8-K/A - EX-16.1 - LETTER TO THE SECURITIES AND EXCHANGE COMMISSION FROM MARCUM BERNSTEIN & PINCHUK LLP DATED OCTOBER 1, 2014. - October 7, 2014

Attached files

file filename
8-K/A - FORM 8-K/A - Bohai Pharmaceuticals Group, Inc.amendmentno2tobohai8kchangeo.htm
EX-16.2 - LETTER TO THE SECURITIES AND EXCHANGE COMMISSION FROM PARKER RANDALL CF (H.K.) CPA LIMITED DATED OCTOBER 1, 2014. - Bohai Pharmaceuticals Group, Inc.parkerexhibit162.htm




[marcumexhibit161002.jpg]






EXHIBIT 16.1




October 1, 2014


Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549


Commissioners:


We have read the statements made by Bohai Pharmaceuticals Group, Inc. under Item 4.01 of its Form 8-K/A dated October 1, 2014. We agree with the statements concerning our Firm in paragraph 1, 2, 3, 4 and 5 in such Form 8-K/A; we are not in a position to agree or disagree with other statements of Bohai Pharmaceuticals Group, Inc. contained therein.


Very truly yours,


/s/Marcum Bernstein & Pinchuk LLP

Marcum Bernstein & Pinchuk LLP







[marcumexhibit161001.jpg]

NEW YORK OFFICE  •  7 Penn Plaza  •  Suite 830 •  New York, New York 10001 •  Phone 646.442.4845 •  Fax 646.349.5200 •  marcumbp.com


Bohai Pharmaceuticals Group, Inc. Reports

Also read